| Time (Central) | Session |
|---|
| 8:00 a.m. | Coffee & Pastries at DRI Headquarters |
| 8:30 a.m. | Welcome and Introductions |
| 8:45 a.m. | Managing Your Business - Profitability and the Art of Succession Planning PFAS litigation continues to evolve in state and federal courts across the country. Learn about the latest developments in the AFFF MDL as well as litigation in other federal and state courts across the country. This session will explore the various personal injury, property damage, water contamination and natural resources claims raised by plaintiffs. Whether you’re involved in PFAS litigation or simply want to keep clients informed of the latest developments, this session will provide an overview of where PFAS litigation stands and what’s likely to come next. Peter Condron, Crowell & Moring LLP, Washington, D.C. |
| 9:45 a.m. | PFAS Regulatory Update for Defendants and Regulated Companies Manufacturers, importers, and retailers are moving from the first wave of PFAS product reporting deadlines into a new phase of ongoing disclosure, supply-chain diligence, and enforcement risk. Join this discussion of lessons learned from early adopting states, including how companies are managing incomplete supplier information, responding to customer inquiries, updating product data, documenting reasonable diligence, and assessing exemptions across a rapidly evolving patchwork of state and federal requirements. As reported information becomes publicly accessible, companies will also need to anticipate how regulators, non-governmental organizations (NGOs), customers, and the media may use PFAS disclosures to identify products, challenge claims, and otherwise generate legal risk for companies. Moderator
Graham Zorn, Beveridge & Diamond PC, Washington, D.C. Elizabeth N. Morrow, Beveridge & Diamond PC, Washington, D.C. |
| 10:45 a.m. | Break |
| 11:00 a.m. | PFAS: Fate and Transport, Remediation Damages, and the Expanding Cost of “Forever Chemical” Litigation PFAS contamination presents major legal and economic risks for property owners, public entities, insurers, and manufacturers. This session will examine scientific issues surrounding PFAS fate and transport—as well as remediation and treatment of PFAS contamination—including filtration, cleanup, and testing and monitoring claims. Panelists will address how hydrogeologic conditions, source identification, treatment options, and remediation evidence may influence litigation strategy, settlement posture, and trial preparation. Moderator
Peter Condron, Crowell & Moring LLP, Washington, D.C. Dylan Eberle, Geosyntec, Acton, MA |
| 12:00 p.m. | DRI Networking Lunch (On-Site) |
| 12:45 p.m. | PFAS Insurance Issues: Coverage, Tender, and Defense Coordination Discuss how insurers and policyholders are addressing PFAS-related claims, with attention to notice and tender issues, historical and current policy language, pollution exclusions, emerging PFAS-specific exclusions, allocation disputes, and practical considerations for preserving coverage positions while coordinating defense, indemnity, and internal risk-management objectives. |
| 1:45 p.m. | Break |
| 2:00 p.m. | PFAS Blood Testing: Science, Experts, and Litigation Implications PFAS blood testing is increasingly raised in litigation, community investigations, and settlement demands, but methods and results have important scientific constraints and legal limitations. This session will help civil litigation defense lawyers and in-house counsel understand what blood tests for PFAS can and cannot show, current public health guidance, and how testing evidence may relate to causation for health effects, class certification, damages, medical monitoring claims, and defense strategy in PFAS-related litigation. Robert P. DeMott, PhD, DABT (Principal Toxicologist), Ramboll, Tampa, FL
Dominique Savinelli, Husch Blackwell LLP, Chicago, IL |
| 3:00 p.m. | Adjourn |